- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Lupin bags US FDA approval for generic Sutab® Tablets. As exclusive first-to-file, it secures 180-day market exclusivity. The branded drug's annual US sales were $132.8M (~₹1102 Cr). Strong potential revenue boost.